The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression: A 12-Week Double-Blind, Randomized Controlled Trial
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Memantine, a noncompetitive N-methyl-d-aspartate receptor antagonist with a mood-stabilizing effect, and an association between bipolar disorder and proinflammatory cytokine levels have been reported. Whether adding-on memantine would reduce cytokine levels and is more effective than valproic acid (VPA) alone in bipolar II disorder was investigated. A randomized, double-blind, controlled, 12-week study was conducted. Patients undergoing regular VPA treatments were randomly assigned to a group: VPA + memantine (5 mg/d) (n = 106) or VPA + placebo (n = 108). The Hamilton Depression Rating Scale (HDRS) and Young Mania Rating Scale (YMRS) were used to evaluate clinical response. Symptom severity, plasma tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), IL-8, and IL-1 levels were examined during weeks 0, 1, 2, 4, 8, and 12. To adjust within-subject dependence over repeated assessments, multiple linear regressions with generalized estimating equation methods were used to examine the therapeutic effect. Tumor necrosis factor α levels were significantly lower in the VPA + memantine group than in the VPA + placebo group (P = 0.013). Posttreatment HDRS and YMRS scores decreased significantly in both groups, but not significant, nor was the other between-group cytokine level difference pretreatment and posttreatment. The HDRS score changes were significantly associated with IL-6 (P = 0.012) and IL-1 (P = 0.005) level changes and changes in YMRS score changes with TNF-α (P = 0.005) level changes. Treating bipolar II depression with VPA + memantine may improve the plasma TNF-α level. However, adding-on memantine may not improve clinical symptoms or cytokine levels other than TNF-α. Clinical symptoms may be correlated with certain cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784 · cited 1×
“Tumor necrosis factor > is a potent proinflammatory cytokine that augments the immune response to assist in eliminating pathogens and resolving the inflammatory challenge.(50) Tumor necrosis factor > has several effects: cytotoxicity, antiviral activity, and regulation of the immune response(51); it may also be a pote…”
BackgroundComparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
Brietzke, E., Stertz, L., Fernandes, B. S., Kauer-Sant’Anna, M., Mascarenhas, M., Escosteguy Vargas, A., Chies, J. A., & Kapczinski, F. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.12.001 · Cited by 423
A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression
Zarate, C. A., Singh, J. B., Quiroz, J. A., De Jesus, G., Denicoff, K. K., Luckenbaugh, D. A., Manji, H. K., & Charney, D. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.153 · Cited by 387
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375
Padmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336
Goldberg, J. F., Perlis, R. H., Bowden, C. L., Thase, M. E., Miklowitz, D. J., Marangell, L. B., Calabrese, J. R., Nierenberg, A. A., & Sachs, G. S. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050746 · Cited by 322
Nery, F. G., Monkul, E. S., Hatch, J. P., Fonseca, M., Zunta‐Soares, G. B., Frey, B. N., Bowden, C. L., & Soares, J. C. (2008) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.912 · Cited by 298
Cytokine profiles in bipolar affective disorder: focus on acutely ill patients.
O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285
Cytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256
Bipolar II disorder: arguments for and against a distinct diagnostic entity
Vieta, E., & Suppes, T. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00561.x · Cited by 200
Research works printed but not linked: 44
- Angst, 2003, Recurrence of bipolar disorders and major depression. A life-long perspective., Eur Arch Psychiatry Clin Neurosci, 253, 236, 10.1007/s00406-003-0437-2 · DOI · Paper page
- Benazzi, 2001, Bipolar II depression in late life: prevalence and clinical features in 525 depressed outpatients., J Affect Disord, 66, 13, 10.1016/S0165-0327(99)00038-5 · DOI
- Benazzi, 2003, Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania., J Affect Disord, 73, 33, 10.1016/S0165-0327(02)00327-0 · DOI · Paper page
- Angst, 2007, The bipolar spectrum., Br J Psychiatry, 190, 189, 10.1192/bjp.bp.106.030957 · DOI · Paper page
- Spence, 2011, Bad medicine: bipolar II disorder., BMJ, 342, d2767, 10.1136/bmj.d2767 · DOI
- Angst, 2003, Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania., J Affect Disord, 73, 133, 10.1016/S0165-0327(02)00322-1 · DOI · Paper page
- Merikangas, 2012, The true prevalence of bipolar II disorder., Curr Opin Psychiatry, 25, 19, 10.1097/YCO.0b013e32834de3de · DOI · Paper page
- Pallanti, 1999, Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder., Am J Psychiatry, 156, 1094, 10.1176/ajp.156.7.1094 · DOI · Paper page
- Vieta, 1997, Differential features between bipolar I and bipolar II disorder., Compr Psychiatry, 38, 98, 10.1016/S0010-440X(97)90088-2 · DOI · Paper page
- Goldstein, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature., J Clin Psychiatry, 70, 1078, 10.4088/JCP.08r04505 · DOI · Paper page
- Breunis, 2003, High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder., Biol Psychiatry, 53, 157, 10.1016/S0006-3223(02)01452-X · DOI
- Knijff, 2007, An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment., Bipolar Disord, 9, 743, 10.1111/j.1399-5618.2007.00444.x · DOI · Paper page
- Soderlund, 2011, Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder., J Psychiatry Neurosci, 36, 114, 10.1503/jpn.100080 · DOI · Paper page
- Knijff, 2006, Monocyte-derived dendritic cells in bipolar disorder., Biol Psychiatry, 59, 317, 10.1016/j.biopsych.2005.06.041 · DOI
- Bosetti, 2002, Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain., Mol Psychiatry, 7, 845, 10.1038/sj.mp.4001111 · DOI
- Rapaport, 2001, The effects of lithium on ex vivo cytokine production., Biol Psychiatry, 50, 217, 10.1016/S0006-3223(01)01144-1 · DOI
- Kowatch, 2005, Treatment guidelines for children and adolescents with bipolar disorder., J Am Acad Child Adolesc Psychiatry, 44, 213, 10.1097/00004583-200503000-00006 · DOI · Paper page
- Yatham, 2009, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009., Bipolar Disord, 11, 225, 10.1111/j.1399-5618.2009.00672.x · DOI · Paper page
- Bauer, 2002, Bipolar disorder., Ment Health Serv Res, 4, 225, 10.1023/A:1020968616616 · DOI
- Beyer, 2002, Volumetric brain imaging findings in mood disorders., Bipolar Disord, 4, 89, 10.1034/j.1399-5618.2002.01157.x · DOI · Paper page
- Wu, 2009, Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation., Neuropsychopharmacology, 34, 2344, 10.1038/npp.2009.64 · DOI · Paper page
- Chipana, 2008, Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents., Neuropharmacology, 54, 1254, 10.1016/j.neuropharm.2008.04.003 · DOI
- Popik, 1996, The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence., Pharmacol Biochem Behav, 53, 791, 10.1016/0091-3057(95)02163-9 · DOI
- Ribeiro Do Couto, 2004, Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice., Prog Neuropsychopharmacol Biol Psychiatry, 28, 1035, 10.1016/j.pnpbp.2004.05.038 · DOI
- Chen, 2012, Low-dose memantine attenuated morphine addictive behavior through its anti-inflammation and neurotrophic effects in rats., J Neuroimmune Pharmacol, 7, 444, 10.1007/s11481-011-9337-9 · DOI
- Parsons, 1999, Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonista review of preclinical data., Neuropharmacology, 38, 735, 10.1016/S0028-3908(99)00019-2 · DOI · Paper page
- Endicott, 1978, A diagnostic interview: the schedule for affective disorders and schizophrenia., Arch Gen Psychiatry, 35, 837, 10.1001/archpsyc.1978.01770310043002 · DOI · Paper page
- Huang, 2004, Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence., Alcohol Clin Exp Res, 28, 374, 10.1097/01.ALC.0000117832.62901.61 · DOI · Paper page
- Akiskal, 1977, Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group., Am J Psychiatry, 134, 1227, 10.1176/ajp.134.11.1227 · DOI · Paper page
- Akiskal, 1979, Differentiation of primary affective illness from situational, symptomatic, and secondary depressions., Arch Gen Psychiatry, 36, 635, 10.1001/archpsyc.1979.01780060025002 · DOI · Paper page
- Angst, 1998, The emerging epidemiology of hypomania and bipolar II disorder., J Affect Disord, 50, 143, 10.1016/S0165-0327(98)00142-6 · DOI · Paper page
- Hamilton, 1960, A rating scale for depression., J Neurol Neurosurg Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Hamilton, 1967, Development of a rating scale for primary depressive illness., Br J Soc Clin Psychol, 6, 278, 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
- Young, 1978, A rating scale for mania: reliability, validity and sensitivity., Br J Psychiatry, 133, 429, 10.1192/bjp.133.5.429 · DOI · Paper page
- Zeger, 1988, Models for longitudinal data: a generalized estimating equation approach., Biometrics, 44, 1049, 10.2307/2531734 · DOI · Paper page
- Bhardwaj, 2003, Receptor-mediated choreography of life and death., J Clin Immunol, 23, 317, 10.1023/A:1025319031417 · DOI
- Kapczinski, 2009, The potential use of biomarkers as an adjunctive tool for staging bipolar disorder., Prog Neuropsychopharmacol Biol Psychiatry, 33, 1366, 10.1016/j.pnpbp.2009.07.027 · DOI · Paper page
- Quan, 2011, Possible antidepressant effects and mechanisms of memantine in behaviors and synaptic plasticity of a depression rat model., Neuroscience, 182, 88, 10.1016/j.neuroscience.2011.03.026 · DOI
- Rogoz, 2002, Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats., Neuropharmacology, 42, 1024, 10.1016/S0028-3908(02)00055-2 · DOI · Paper page
- Koukopoulos, 2012, The sustained mood-stabilizing effect of memantine in the management of treatment resistant bipolar disorders: findings from a 12-month naturalistic trial., J Affect Disord, 136, 163, 10.1016/j.jad.2011.09.040 · DOI
- Muhonen, 2008, Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence., J Clin Psychiatry, 69, 392, 10.4088/JCP.v69n0308 · DOI · Paper page
- Zdanys, 2008, A systematic review of off-label uses of memantine for psychiatric disorders., Prog Neuropsychopharmacol Biol Psychiatry, 32, 1362, 10.1016/j.pnpbp.2008.01.008 · DOI
- Goldberg, 1998, Association of recurrent suicidal ideation with nonremission from acute mixed mania., Am J Psychiatry, 155, 1753, 10.1176/ajp.155.12.1753 · DOI · Paper page
- Pan, 1999, Penetration of neurotrophins and cytokines across the blood-brainblood-spinal cord barrier., Adv Drug Deliv Rev, 36, 291, 10.1016/S0169-409X(98)00086-6 · DOI
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Rosenblat, J., & McIntyre, R. (2017) · Brain Sciences · doi:10.3390/brainsci7110144 · Cited by 258
Bahji, A., Ermacora, D., Stephenson, C., Hawken, E. R., & Vazquez, G. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.030 · Cited by 139
Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults
McCloud, T. L., Caddy, C., Jochim, J., Rendell, J. M., Diamond, P. R., Shuttleworth, C., Brett, D., Amit, B. H., McShane, R., Hamadi, L., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011611.pub2 · Cited by 102
Wang, T.-Y., Lee, S.-Y., Chen, S.-L., Chang, Y.-H., Wang, L.-J., Chen, P. S., Chen, S.-H., Chu, C.-H., Huang, S.-Y., Tzeng, N.-S., et al. (2016) · Scientific Reports · doi:10.1038/srep27431 · Cited by 21
Self-citation
Metadata
- Authors
- Lee, S.-Y., Chen, S.-L., Chang, Y.-H., Chen, P. S., Huang, S.-Y., Tzeng, N.-S., Wang, Y.-S., Wang, L.-J., Lee, I. H., Wang, T.-Y., Yeh, T. L., Yang, Y. K., Hong, J.-S., & Lu, R.-B.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2014-06
- Volume
- 34
- Issue
- 3
- Pages
- 337-343
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W1965692095
- Cited by
- 45
- References
- 14
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression: A 12-Week Double-Blind, Randomized Controlled Trial. https://app.cochat.ai/papers/10.1097/jcp.0000000000000109
- The paper
- Lee, S.-Y., Chen, S.-L., Chang, Y.-H., Chen, P. S., Huang, S.-Y., Tzeng, N.-S., Wang, Y.-S., Wang, L.-J., Lee, I. H., Wang, T.-Y., Yeh, T. L., Yang, Y. K., Hong, J.-S., & Lu, R.-B. (2014). The Effects of Add-On Low-Dose Memantine on Cytokine Levels in Bipolar II Depression: A 12-Week Double-Blind, Randomized Controlled Trial. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000109
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.